Nice find Player. Dr Gray won't lie down. Difficult to understand what his aim is given he owns about 18% of SRX.
http://whois.domaintools.com/betabeads.us
Competition is always a risk I guess, but with SRX being the biggest provider with less than 1% of the market and already an existing competitor in the market in Nordion any further attention is probably good, to help build the profile of the treatment option.
I'd imagine that a larger company may well be interested in this type of treatment option. Given SRX's current market cap I'd say the easiest way to get traction for a large Pharma would be to put a bid in for SRX than start from scratch.
Or maybe I just have my head in the sand.
Nice find Player. Dr Gray won't lie down. Difficult to...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.27M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.0¢ | 17.5¢ | $132.6K | 758.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 449688 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 955405 | 27 |
View Market Depth
| Last trade - 15.47pm 30/08/2024 (20 minute delay) ? |
| SRX (ASX) Chart |